Matrix metalloproteinase (MMP)-2 inhibitor 1 induces osteogenesis differentiation of bone marrow mesenchymal stem cells (BMSCs) and promotes type H vessel angiogenesis to rescue osteoporosis through the HIF-1α signaling pathway [79]. The gene discussed is HIF1A; the disease is osteoporosis.